ROYAL BANK OF CANADA - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 112 filers reported holding ALBIREO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$51,000
+410.0%
2,397
+398.3%
0.00%
Q3 2022$10,000
+233.3%
481
+270.0%
0.00%
Q2 2022$3,000
-90.3%
130
-87.5%
0.00%
Q1 2022$31,000
-64.4%
1,036
-72.4%
0.00%
Q4 2021$87,000
+93.3%
3,750
+159.5%
0.00%
Q3 2021$45,0000.0%1,445
+15.1%
0.00%
Q2 2021$45,000
+9.8%
1,255
+8.9%
0.00%
Q1 2021$41,000
+2.5%
1,152
+8.5%
0.00%
Q4 2020$40,000
+135.3%
1,062
+109.5%
0.00%
Q3 2020$17,0000.0%507
-19.4%
0.00%
Q2 2020$17,000
+466.7%
629
+288.3%
0.00%
Q1 2020$3,000
-83.3%
162
-75.9%
0.00%
Q4 2019$18,000
+800.0%
672
+572.0%
0.00%
Q3 2019$2,000
-33.3%
1000.0%0.00%
Q2 2019$3,0000.0%1000.0%0.00%
Q1 2019$3,000
+50.0%
1000.0%0.00%
Q4 2018$2,000
-77.8%
100
-63.4%
0.00%
Q3 2018$9,000
+28.6%
273
+54.2%
0.00%
Q2 2018$7,000
+133.3%
177
+77.0%
0.00%
Q1 2018$3,000100
+900.0%
0.00%
Q4 2017$0100.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Prosight Management, LP 514,082$11,973,0007.17%
Privium Fund Management B.V. 379,117$8,959,0001.78%
Birchview Capital, LP 113,000$2,632,0001.70%
Sio Capital Management, LLC 213,913$4,982,0001.50%
Perceptive Advisors 4,720,278$109,936,0000.85%
Chicago Capital, LLC 849,239$19,779,0000.74%
APOGEM CAPITAL LLC 38,601$899,0000.59%
Samsara BioCapital, LLC 100,000$2,329,0000.45%
Artal Group S.A. 600,000$13,974,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 458,011$10,667,0000.38%
View complete list of ALBIREO PHARMA INC shareholders